Three years ago, 24-sept-2004,
the value pps was 1.85 Dollar.
And that was pps, without approval ATryn EU, without almost now approval ATryn US, without LFB, without PharmAthene, without Trial Phase II ATryn DIC in Sepsis, without better Trials RA, Psoriasis and Uveitis.
Without ... Today, pps 1.06 Dollar?
Can you hear the Management? Silence?
Where are all those IP-agreements?